Dabur India Ltd
NSE: DABUR BSE: 500096FMCG
Dabur is India’s leading FMCG, Ayurvedic and natural health care company with wide network distribution across world. [1]
₹458
52W: ₹401 — ₹577
PE 54.1 · Book ₹42.4 · +980% vs bookMarket Cap₹81,217 Cr
Stock P/E54.1Price to Earnings
ROCE25.1%Return on Capital
ROE20.1%Return on Equity
Div. Yield1.74%Face Value ₹1
Strengths
- +Company is almost debt free.
- +Company has been maintaining a healthy dividend payout of 87.9%
- +Debtor days have improved from 23.8 to 18.4 days.
Weaknesses
- −Stock is trading at 10.8 times its book value
- −The company has delivered a poor sales growth of 5.48% over past five years.
- −Working capital days have increased from 6.10 days to 85.8 days
Shareholding Pattern
Promoters66.25%
FIIs9.98%
DIIs18.46%
Public5.2%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 66.25% | 66.25% | 66.27%▲0.0 | 66.28%▲0.0 | 66.22%▼0.1 | 66.22% | 66.23%▲0.0 | 66.25%▲0.0 |
| FIIs | 14.99% | 15.05%▲0.1 | 13.28%▼1.8 | 12.68%▼0.6 | 11.85%▼0.8 | 10.88%▼1.0 | 10.05%▼0.8 | 9.98%▼0.1 |
| DIIs | 13.45% | 13.57%▲0.1 | 14.85%▲1.3 | 15.62%▲0.8 | 16.16%▲0.5 | 17.29%▲1.1 | 18.29%▲1.0 | 18.46%▲0.2 |
| Public | 5.26% | 5.07%▼0.2 | 5.53%▲0.5 | 5.36%▼0.2 | 5.69%▲0.3 | 5.48%▼0.2 | 5.33%▼0.2 | 5.2%▼0.1 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,414 | 2,039 | 2,514 | 2,144 | 2,448 | 1,965 | 2,470 | 2,235 | 2,547 | 2,132 |
| Expenses | 1,883 | 1,703 | 2,017 | 1,740 | 1,926 | 1,680 | 1,984 | 1,811 | 1,992 | 1,815 |
| Operating Profit | 532 | 337 | 497 | 403 | 523 | 284 | 485 | 424 | 555 | 317 |
| OPM % | 22% | 16% | 20% | 19% | 21% | 14% | 20% | 19% | 22% | 15% |
| Net Profit | 428 | 283 | 405 | 329 | 418 | 251 | 407 | 349 | 439 | 296 |
| EPS ₹ | 2.42 | 1.6 | 2.29 | 1.86 | 2.36 | 1.41 | 2.3 | 1.97 | 2.48 | 1.67 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹9,383Cr, up 3.4% YoY. OPM at 19%.
Debt Position
Borrowings at ₹611Cr. Debt-to-equity ratio: 0.08x. Healthy balance sheet.
Capex Cycle
CWIP at ₹108Cr (5% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 18.46% (+9.71pp change). FIIs: 9.98% (-9.41pp change). Promoters hold 66.25%.
Margin & Efficiency
ROCE declining from 45% (Mar 2015) to 25% (Mar 2026). Working capital days: 86.
Valuation
PE 54.1x with 25.1% ROCE. Price is 980% above book value of ₹42.4. Dividend yield: 1.74%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 12 May - Dabur released Q4 FY26 investor call transcript, citing 7.3% revenue growth and 15% PAT growth.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 8 May - Newspaper publication of Audited Financial Results for the quarter and financial year ended March 31, 2026
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 7 May - Audio recording link for Dabur’s Q4 FY2025-26 investor conference call issued on May 7, 2026.
- Fixation Of Record Date For Ascertainment Of Shareholders Entitled To Receive The Dividend 7 May - Dabur sets July 17 record date, July 20-24 book closure for Rs. 5.50 final dividend.
- Announcement under Regulation 30 (LODR)-Date of payment of Dividend 7 May - Record date July 17, 2026; book closure July 20-24 for Rs.5.50 final dividend.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse